ACHIKO AG/ CH0522213468 /
10/10/2023 15:49:31 | Chg. 0.000 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
0.001CHF | 0.00% | 10 Turnover: .014 |
-Bid Size: - | -Ask Size: - | 0.001 | 0.001 |
GlobeNewswire
27/01/2022
Achiko AG Strengthens Senior Team with Appointment of Head of Corporate Development
GlobeNewswire
18/01/2022
Achiko AG Announces Feature Article on “How We Get Back to Normal” with its AptameX™ Covid-19 Rapid ...
GlobeNewswire
14/01/2022
Achiko AG Reports Breakthrough Calibration Results for its AptameX™ Covid-19 Rapid Test Technology
GlobeNewswire
23/12/2021
Achiko AG Looks Back at Pivotal Year and Reaffirms Commitment to Provide Affordable and Accurate COV...
GlobeNewswire
08/12/2021
Achiko’s Commercialization Update: Optimized Second-Generation Covid-19 Diagnostic Test Receives Ful...
GlobeNewswire
25/08/2021
Achiko’s Rapid Covid-19 Diagnostic Test AptameX™ Receives Product and Registration Approval from Ind...
GlobeNewswire
15/07/2021
Achiko Engages EpiMetrics to Expand Covid-19 Testing Operations with Udayana University in Bali, Ind...
GlobeNewswire
13/07/2021
Achiko Working Towards a Solution for Frequent Global Mass COVID-19 Testing
GlobeNewswire
18/06/2021
Achiko Announces an Extension of its Convertible Loan Transaction with Negma Group
GlobeNewswire
03/06/2021
Achiko Announces the Successful Integration of its Teman Sehat Digital Ecosystem and AptameX Covid-1...
GlobeNewswire
03/06/2021
Achiko AG Announces Successful Integration of its Teman Sehat Digital Ecosystem and AptameX Covid-19...
GlobeNewswire
20/05/2021
Achiko Completes Initial Shipment of AptameX, its Progressive Covid-19 Diagnostic Test to Indonesia,...
GlobeNewswire
04/05/2021
Achiko Appoints New Chief Financial Officer and Announces Changes to Senior Team